Physician profile
Scott N Schimpff
NPI 1376740191
$8,286.32
in general payments reported to CMS, 2019-2025
52 companies · $1,041 in 2025
The $1,041 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,435 · 2020: $991 · 2021: $1,422 · 2022: $1,089 · 2023: $1,107 · 2024: $1,201 · 2025: $1,041.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,348.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,093.45 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $966.59 | 2019-2025 | Relistor |
| Boston Scientific Corporation | $765.20 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Bionic Navigator |
| Amgen INC. | $674.54 | 2019-2022 | |
| Abbvie INC. | $585.25 | 2021-2025 | Vraylar, Qulipta, Ubrelvy |
| Collegium Pharmaceutical, INC. | $536.95 | 2019-2025 | Xtampza, Belbuca |
| Medtronic USA, INC. | $350.11 | 2019-2020 | |
| Abbott Laboratories | $305.06 | 2020-2025 | Proclaim, Eterna |
| Vertos Medical, INC. | $257.58 | 2021-2024 | Mild Device Kit |
| Novartis Pharmaceuticals Corporation | $257.32 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $143.94 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $136.41 | 2021 | |
| Nevro Corp. | $130.90 | 2019-2023 | Senza |
| Tersera Therapeutics LLC | $126.77 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $125.96 | 2019-2020 |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Schimpff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.